Corvus registers Phase 1b trial of soquelitinib in hidradenitis suppurativaSep 18Trial updateCorvus Pharmaceuticals, Inc.soquelitinib
Aclaris reports Q2 2026 results, ATI-052 Phase 1a data and reaffirmed timelinesAug 6Quarterly updateAclaris Therapeutics, Inc.
Corvus reports Q2 2026 results, updates soquelitinib pipeline progressAug 6Quarterly updateCorvus Pharmaceuticals, Inc.soquelitinib
Sign inSign in